NEWTON (PTC) Ltd - 30 Sep 2025 SCHEDULE 13G/A Report for LYELL IMMUNOPHARMA, INC. Common Stock, $0.0001 par value per share (LYEL)

Filing Manager: NEWTON (PTC) Ltd
Reporting Manager: Newton (PTC) Limited
Security: LYELL IMMUNOPHARMA, INC. Common Stock, $0.0001 par value per share
Symbol: LYEL
Shares outstanding: 19.2M shares
Disclosed Ownership: 755K shares
Ownership: 3.93%
Form type: SCHEDULE 13G/A
Filing time: 12 Nov 2025, 16:57:35 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Newton (PTC) Limited	3.93%	755K	755K	/s/ David Muir	David Muir / President
Orland Properties Limited	3.93%	755K	755K	//s/ David Muir	David Muir / President
Gemini GP Limited	3.93%	755K	755K	/s/ David Muir	David Muir / President
Gemini Investments, L.P.	3.93%	755K	755K	By: Gemini GP Limited, its General Partner /s/ David Muir	David Muir / President